AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • May 10th, 2017 • Aevi Genomic Medicine, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 1 to License Agreement (this “Amendment”) is made and entered into as of the 14th day of February 2017 (the “Amendment Effective Date”) by and between The Children’s Hospital of Philadelphia, a non-profit entity organized and existing under the laws of Pennsylvania and having a principal place of business at 34th and Civic Center Boulevard, Philadelphia, PA 19104 USA (“CHOP”), and Medgenics Medical Israel Ltd., a company organized under the laws of the State of Israel and having a principal place of business at Misgav Business Park, Rechov Kahol 2, Misgav 20179 Israel (“Licensee”). CHOP and Licensee are sometimes referred to in this Amendment individually as a “Party” and collectively as the “Parties.”
Amendment #2 to Sponsored Research AgreementSponsored Research Agreement • May 10th, 2017 • Aevi Genomic Medicine, Inc. • Biological products, (no disgnostic substances)
This Amendment #2 to Sponsored Research Agreement (this “Amendment #2”), executed on November 12, 2014 (“Agreement”), is made and entered into as of November 30, 2016 (“Amendment #2 Effective Date”) by and between Medgenics Medical Israel, Ltd. (“SPONSOR”) and The Children’s Hospital of Philadelphia (“CHOP”).
